Cetera Advisor Networks LLC Bio Techne Corp Transaction History

Cetera Advisor Networks LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$65.98 - $77.09 $48,561 - $56,738	736 Added 6.44%	12,165 $856,000
Q4 2023 Feb 13, 2024	SELL	$52.83 - $78.22 $56,897 - $84,242	-1,077 Reduced 8.61%	11,429 $881,000
Q3 2023 Nov 14, 2023	SELL	$67.52 - $89.42 $140,846 - $186,530	-2,086 Reduced 14.3%	12,506 $851,000
Q2 2023 Aug 09, 2023	SELL	$73.76 - $85.98 $58,491 - $68,182	-793 Reduced 5.15%	14,592 $1.19 Million
Q1 2023 May 15, 2023	SELL	$71.62 - $86.62 $50,706 - $61,326	-708 Reduced 4.4%	15,385 $1.14 Million
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $1.1 Million - $4.78 Million	13,580 Added 540.39%	16,093 $1.33 Million
Q3 2022 Nov 10, 2022	SELL	$282.54 - $391.85 $1,977 - $2,742	-7 Reduced 0.28%	2,513 $714,000
Q2 2022 Aug 11, 2022	BUY	$322.67 - $449.65 $642,113 - $894,803	1,990 Added 375.47%	2,520 $873,000
Q4 2021 Feb 14, 2022	BUY	$456.15 - $525.06 $50,176 - $57,756	110 Added 26.19%	530 $274,000
Q3 2021 Nov 16, 2021	BUY	$444.87 - $538.88 $186,845 - $226,329	420 New	420 $204,000
Q3 2020 Nov 13, 2020	SELL	$232.22 - $282.96 $55,268 - $67,344	-238 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$185.43 - $279.56 $44,132 - $66,535	238 New	238 $63,000

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.79B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.